Literature DB >> 8534235

Resistance of Fasciola hepatica to triclabendazole.

D J Overend1, F L Bowen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8534235     DOI： 10.1111/j.1751-0813.1995.tb03546.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN： 0005-0423            Impact factor:   1.281


× No keyword cloud information.
  53 in total

1.  Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep.

Authors:  Luis A Gomez-Puerta; Cesar Gavidia; Maria T Lopez-Urbina; Hector H Garcia; Armando E Gonzalez
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  FhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains.

Authors:  Rebecca Orr; Ruth Kinkead; Richard Newman; Lindsay Anderson; Elizabeth M Hoey; Alan Trudgett; David J Timson
Journal:  Parasitol Res       Date:  2012-07-08       Impact factor: 2.289

3.  Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica.

Authors:  José F Gaudier; Kimberly Cabán-Hernández; Antonio Osuna; Ana M Espino
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

4.  Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics.

Authors:  Supeecha Kumkate; Supatra Chunchob; Tavan Janvilisri
Journal:  Mol Cell Biochem       Date:  2008-06-10       Impact factor: 3.396

5.  In vitro ovicidal activity of Peganum harmala seeds extract on the eggs of Fasciola hepatica.

Authors:  Mohammad Moazeni; Zahra Sadat Saadaty Ardakani; Mohammad Jamal Saharkhiz; Jafar Jalaei; Ali Asghar Khademolhoseini; Shahab Shams Esfand Abad; Amir Mootabi Alavi
Journal:  J Parasit Dis       Date:  2016-08-29

6.  Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.

Authors:  Ana M Espino; Adelaida Morales; Bonnibel Delgado; Francheska M Rivera; Olgary Figueroa; Erick Suárez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

7.  Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.

Authors:  M McConville; G P Brennan; M McCoy; R Castillo; A Hernandez-Campos; F Ibarra; I Fairweather
Journal:  Parasitol Res       Date:  2006-10-03       Impact factor: 2.289

8.  Evidence for multiple mitochondrial lineages of Fasciola hepatica (liver fluke) within infrapopulations from cattle and sheep.

Authors:  S M Walker; P A Prodöhl; H L Fletcher; R E B Hanna; V Kantzoura; E M Hoey; A Trudgett
Journal:  Parasitol Res       Date:  2007-01-11       Impact factor: 2.289

9.  Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.

Authors:  Ana M Espino; Daricel Torres; Adelaida Morales; Bonnibel Delgado; Julia Quetel; Antonio Osuna
Journal:  Exp Parasitol       Date:  2007-03-27       Impact factor: 2.011

10.  The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-08-09       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.